Soliris®

Soliris (eculizumab) is a monoclonal antibody that binds to proteins in the blood that can destroy red blood cells. Specifically it is a complement inhibitor antibody used to treat myasthenia gravis and certain hemolytic (blood-related) syndromes.

For more information, visit the patient website for this drug. Speak with your healthcare provider to learn if this drug is right for you.

Manufacturer:

Alexion Pharmaceuticals

Class:

Biologics (complement inhibitors)

What It Treats:

  • Myasthenia Gravis (in patients who are acetyl-choline receptor antibody positive)
  • Paroxysmal Nocturnal Hemoglobinuria (PNH)
  • Atypical Hemolytic Uremic syndrome (aHUS)

PRESCRIBED BY:

Neurologists

HOW ADMINISTERED:

IV infusion

FREQUENCY:

Every other week

Length of infusion:

About 45 minutes

RELATED DRUGS:

Ultomiris